CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 34 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $619,000 | -9.6% | 47,237 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $685,000 | +23.2% | 47,237 | +1.8% | 0.00% | 0.0% |
| Q2 2016 | $556,000 | -14.3% | 46,413 | +33.3% | 0.00% | 0.0% |
| Q1 2016 | $649,000 | -11.2% | 34,820 | +2.4% | 0.00% | 0.0% |
| Q4 2015 | $731,000 | +27.1% | 34,011 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $575,000 | -55.8% | 33,938 | -2.3% | 0.00% | -50.0% |
| Q2 2015 | $1,302,000 | – | 34,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|